After Angeline Jolie revealed in an op-ed for the New York Times that she had the mutated BRCA1 gene and had undergone a preventative double mastectomy, the world took notice. The latest edition of Time Magazine examines “The Angelina Effect” on how her decision puts genetic testing in the spotlight.
↧